Dysregulation of sterol regulatory element binding protein-1c in livers of morbidly obese women is associated with altered suppressor of cytokine signaling-3 and signal transducer and activator of transcription-1 signaling

Metabolism: Clinical and Experimental

Volumn 59, Issue 4, 2010, Pages 587-598

  Elam, Marshall B ^a,b   Yellaturu, Chandrahasa ^b   Howell, George E ^b   Deng, Xiong ^b   Cowan, George S ^b   Kumar, Poonam ^b   Park, Edwards A ^b   Hiler, M Lloyd ^b   Wilcox, Henry G ^b   Hughes, Thomas A ^b   Cook, George A ^b   Raghow, Rajendra ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; FATTY ACID SYNTHASE; JANUS KINASE; STAT1 PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ABDOMINAL WALL HERNIA; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GENE EXPRESSION; HUMAN; INSULIN RESISTANCE; LIPOGENESIS; LIVER BIOPSY; MICROARRAY ANALYSIS; MORBID OBESITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH BYPASS; WEIGHT REDUCTION; WESTERN BLOTTING;

ADULT; FATTY ACIDS; FEMALE; GASTRIC BYPASS; GENE EXPRESSION REGULATION; HUMANS; HYDROCARBONS, FLUORINATED; INSULIN; INSULIN RESISTANCE; LIPOPROTEINS, VLDL; LIVER; OBESITY, MORBID; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; STEAROYL-COA DESATURASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SULFONAMIDES; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRIGLYCERIDES; WEIGHT LOSS;

EID: 77949484430     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.09.001     Document Type: Article

References (47)

1. Grundy S.M. Metabolic complications of obesity. Endocrine 13 (2000) 155-165
2. Castro Cabezas M., Halkes C.J., and Erkelens D.W. Obesity and free fatty acids: double trouble. Nutr Metab Cardiovasc Dis 11 (2001) 134-142
3. Festi D., Colecchia A., Sacco T., Bondi M., Roda E., and Marchesini G. Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes Rev 5 (2004) 27-42
4. Marchesini G., Marzocchi R., Agostini F., and Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 16 (2005) 421-427
5. Hellerstein M.K., Christiansen M., Kaempfer S., Kletke C., Wu K., Reid J.S., et al. Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J Clin Invest 87 (1991) 1841-1852
6. Faix D., Neese R., Kletke C., Wolden S., Cesar D., Coutlangus M., et al. Quantification of menstrual and diurnal periodicities in rates of cholesterol and fat synthesis in humans. J Lipid Res 34 (1993) 2063-2075
7. Schwarz J.M., Neese R.A., Turner S., Dare D., and Hellerstein M.K. Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. J Clin Invest 96 (1995) 2735-2743
8. Hudgins L.C., Hellerstein M., Seidman C., Neese R., Diakun J., and Hirsch J. Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. J Clin Invest 97 (1996) 2081-2091
9. Lammert O., Grunnet N., Faber P., Bjornsbo K.S., Dich J., Larsen L.O., et al. Effects of isoenergetic overfeeding of either carbohydrate or fat in young men. Br J Nutr 84 (2000) 233-245
10. Shimomura I., Bashmakov Y., and Horton J.D. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem. 1999 October 15 274 (1999) 30028-30032
11. Elam M.B., Wilcox H.G., Cagen L.M., Deng X., Raghow R., Kumar P., et al. Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat. J Lipid Res 42 (2001) 2039-2048
12. Cagen L.M., Deng X., Wilcox H.G., Park E.A., Raghow R., and Elam M.B. Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements. Biochem J 385 Pt 1 (2005) 207-216
13. Dif N., Euthine V., Gonnet E., Laville M., Vidal H., and Lefai E. Insulin activates human sterol-regulatory-element-binding protein-1c (SREBP-1c) promoter through SRE motifs. Biochem J 400 (2006) 179-188
14. Hegarty B.D., Bobard A., Hainault I., Ferre P., Bossard P., and Foufelle F. Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c. Proc Natl Acad Sci U S A 102 (2005) 791-796
15. Yellaturu C.R., Deng X., Cagen L.M., Wilcox H.G., Mansbach Jr. C.M., Siddiqi S.A., et al. Insulin enhances posttranslational processing of nascent SREBP-1c by promoting its phosphorylation and association with COPII vesicles. J Biol Chem 284 (2009) 7518-7532
16. Raghow R., Yellaturu C., Deng X., Park E.A., and Elam M.B. SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends Endocrinol Metab 19 (2008) 65-73
17. Shimomura I., Matsuda M., Hammer R.E., Bashmakov Y., Brown M.S., and Goldstein J.L. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6 (2000) 77-86
18. Biddinger S.B., and Kahn C.R. From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 68 (2006) 123-158
19. Emanuelli B., Peraldi P., Filloux C., Chavey C., Freidinger K., Hilton D.J., et al. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J Biol Chem 276 (2001) 47944-47949
20. Ueki K., Kondo T., and Kahn C.R. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol 24 (2004) 5434-5446
21. Ueki K., Kadowaki T., and Kahn C.R. Role of suppressors of cytokine signaling SOCS-1 and SOCS-3 in hepatic steatosis and the metabolic syndrome. Hepatol Res 33 (2005) 185-192
22. Buchwald H., Avidor Y., Braunwald E., Jensen M.D., Pories W., Fahrbach K., et al. Bariatric surgery: a systematic review and meta-analysis. Jama 292 (2004) 1724-1737
23. Elam M.B., Cowan Jr. G.S., Rooney R.J., Hiler M.L., Yellaturu C.R., Deng X., et al. Hepatic gene expression in morbidly obese women: implications for disease susceptibility. Obesity (Silver Spring) 17 (2009) 1563-1573
24. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999) 1462-1470
25. Hughes T.A., Elam M.B., Applegate W.B., Bond M.G., Hughes S.M., Wang X., et al. Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease. Metabolism 44 (1995) 1082-1098
26. Lockhart D.J., Dong H., Byrne M.C., Follettie M.T., Gallo M.V., Chee M.S., et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14 (1996) 1675-1680
27. Deng X., Yellaturu C., Cagen L., Wilcox H.G., Park E.A., Raghow R., et al. Expression of the rat sterol regulatory element-binding protein-1c gene in response to insulin is mediated by increased transactivating capacity of specificity protein 1 (Sp1). J Biol Chem 282 (2007) 17517-17529
28. Ueki K., Kondo T., Tseng Y.H., and Kahn C.R. Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci U S A 101 (2004) 10422-10427
29. Bode J.G., Ludwig S., Freitas C.A., Schaper F., Ruhl M., Melmed S., et al. The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription. Biol Chem 382 (2001) 1447-1453
30. Yabe D., Komuro R., Liang G., Goldstein J.L., and Brown M.S. Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis. Proc Natl Acad Sci U S A 100 (2003) 3155-3160
31. Yellaturu C.R., Deng X., Cagen L.M., Wilcox H.G., Park E.A., Raghow R., et al. Posttranslational processing of SREBP-1 in rat hepatocytes is regulated by insulin and cAMP. Biochem Biophys Res Commun 332 (2005) 174-180
32. Endo M., Masaki T., Seike M., and Yoshimatsu H. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c). Exp Biol Med (Maywood) 232 (2007) 614-621
33. Chan D.C., Watts G.F., Redgrave T.G., Mori T.A., and Barrett P.H. Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration. Metabolism 51 (2002) 1041-1046
34. Mittendorfer B., Patterson B.W., and Klein S. Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity. Am J Physiol Endocrinol Metab 284 (2003) E549-E556
35. Deng X., Elam M.B., Wilcox H.G., Cagen L.M., Park E.A., Raghow R., et al. Dietary olive oil and menhaden oil mitigate induction of lipogenesis in hyperinsulinemic corpulent JCR:LA-cp rats: microarray analysis of lipid-related gene expression. Endocrinology 145 (2004) 5847-5861
36. Havel R.J.K.J., Segel E.O., and Basso L.V. Splanchnic metabolism of free fatty acids and production of triglyceride of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J Clin Invest 49 (1970) 2017-2035
37. Egusa G., Beltz W.F., Grundy S.M., and Howard B.V. Influence of obesity on the metabolism of apolipoprotein B in humans. J Clin Invest 76 (1985) 596-603
38. Aarsland A., Chinkes D., and Wolfe R.R. Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. J Clin Invest 98 (1996) 2008-2017
39. Horton J.D., Goldstein J.L., and Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109 (2002) 1125-1131
40. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100 (2003) 8466-8471
41. Rufo C., Teran-Garcia M., Nakamura M.T., Koo S.H., Towle H.C., and Clarke S.D. Involvement of a unique carbohydrate-responsive factor in the glucose regulation of rat liver fatty-acid synthase gene transcription. J Biol Chem 276 (2001) 21969-21975
42. Kenler H.A., Brolin R.E., and Cody R.P. Changes in eating behavior after horizontal gastroplasty and Roux-en-Y gastric bypass. Am J Clin Nutr 52 (1990) 87-92
43. Havel P.J. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 63 (2005) 133-157
44. Takemoto T., Nishio Y., Sekine O., Ikeuchi C., Nagai Y., Maeno Y., et al. RBMX is a novel hepatic transcriptional regulator of SREBP-1c gene response to high-fructose diet. FEBS Lett 581 (2007) 218-222
45. Dobrzyn A., and Ntambi J.M. Stearoyl-CoA desaturase as a new drug target for obesity treatment. Obes Rev 6 (2005) 169-174
46. Leonard A.E., Kelder B., Bobik E.G., Chuang L.T., Lewis C.J., Kopchick J.J., et al. Identification and expression of mammalian long-chain PUFA elongation enzymes. Lipids 37 (2002) 733-740
47. Matsuzaka T., Shimano H., Yahagi N., Kato T., Atsumi A., Yamamoto T., et al. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nat Med. 13 (2007) 1193-1202